Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

80.50
EUR
-1.50
(-1.83%)
-3.46EPS
4.36BMarket Cap
Mar 16Next Earn

Dianthus Therapeutics, Inc. Documents

Q3 FY2025 · Presentation

Dianthus_Corp Presentation_November_2025_11.12.2025 · 72 pages

Read Dianthus Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q3 FY2025 documents